Published in J Geriatr Psychiatry Neurol on March 01, 2007
The role of executive function and attention in gait. Mov Disord (2008) 5.03
Effects of single-task versus dual-task training on balance performance in older adults: a double-blind, randomized controlled trial. Arch Phys Med Rehabil (2009) 1.47
Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer's disease. Arch Phys Med Rehabil (2010) 1.18
Training-related changes in dual-task walking performance of elderly persons with balance impairment: a double-blind, randomized controlled trial. Gait Posture (2009) 1.14
A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS One (2013) 1.10
Methods to Enhance Verbal Communication between Individuals with Alzheimer's Disease and Their Formal and Informal Caregivers: A Systematic Review. Int J Alzheimers Dis (2010) 0.96
Discourse coherence and cognition after stroke: a dual task study. J Commun Disord (2010) 0.90
Effectiveness of exercise on cognitive impairment and Alzheimer's disease. Int J Gen Med (2013) 0.82
Maintaining Gait Performance by Cortical Activation during Dual-Task Interference: A Functional Near-Infrared Spectroscopy Study. PLoS One (2015) 0.81
Dual task-related gait changes in patients with mild cognitive impairment. Funct Neurol (2015) 0.81
[Gait changes as an early indicator of dementia]. Z Gerontol Geriatr (2012) 0.78
A longitudinal study of physical function in patients with early-onset dementia. Dement Geriatr Cogn Dis Extra (2012) 0.77
Effect of dual tasks on balance ability in stroke patients. J Phys Ther Sci (2015) 0.77
Performance-based assessment of falls risk in older veterans with executive dysfunction. J Rehabil Res Dev (2014) 0.76
Adaptive walking in Alzheimer's disease. Int J Alzheimers Dis (2012) 0.76
Gait, dual task and history of falls in elderly with preserved cognition, mild cognitive impairment, and mild Alzheimer's disease. Braz J Phys Ther (2017) 0.75
Improving Dual-Task Walking Paradigms to Detect Prodromal Parkinson's and Alzheimer's Diseases. Front Neurol (2017) 0.75
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol (2009) 3.65
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol (2006) 2.16
Risk factors in late adolescence for young-onset dementia in men: a nationwide cohort study. JAMA Intern Med (2013) 2.15
[Cognitive medicine--field of knowledge for future specialist education]. Lakartidningen (2008) 2.03
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology (2004) 2.00
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke (2006) 1.88
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Walking function, pain, and fatigue in adults with cerebral palsy: a 7-year follow-up study. Dev Med Child Neurol (2008) 1.73
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry (2012) 1.57
Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype. Aust N Z J Psychiatry (2012) 1.53
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Neurochemical aftermath of amateur boxing. Arch Neurol (2006) 1.47
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry (2011) 1.35
Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol (2002) 1.34
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 1.30
Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord (2002) 1.30
A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl (2003) 1.29
Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett (2003) 1.29
MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci (2009) 1.28
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology (2013) 1.27
White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry (2006) 1.26
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24
Application and comparison of classification algorithms for recognition of Alzheimer's disease in electrical brain activity (EEG). J Neurosci Methods (2006) 1.24
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype. Dement Geriatr Cogn Disord (2009) 1.23
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals. Neurochem Res (2008) 1.19
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr (2008) 1.16
Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology (2012) 1.16
Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage (2003) 1.14
Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10
The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. Neurosci Lett (2007) 1.09
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Exp Gerontol (2009) 1.09
Structural correlates of mild cognitive impairment. Neurobiol Aging (2004) 1.09
Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. Neurobiol Aging (2009) 1.09
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2010) 1.08
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J Alzheimers Dis (2013) 1.07
Segmentation of age-related white matter changes in a clinical multi-center study. Neuroimage (2008) 1.06
Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One (2011) 1.06
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry (2006) 1.05
Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res (2013) 1.05
White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke (2012) 1.05
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement (2008) 1.05
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci Lett (2009) 1.03
Effects of new, individually adjusted, progressive balance group training for elderly people with fear of falling and tend to fall: a randomized controlled trial. Clin Rehabil (2011) 1.02
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc (2006) 1.01
Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.00
APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord (2010) 1.00
Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res (2008) 0.99
Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis. Neuroradiology (2012) 0.99
Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med (2004) 0.99
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging (2012) 0.98
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol (2008) 0.98
Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol Aging (2007) 0.98
Intracranial volume in mild cognitive impairment, Alzheimer's disease and vascular dementia: evidence for brain reserve? Int J Geriatr Psychiatry (2004) 0.98
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. J Alzheimers Dis (2011) 0.98
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry (2008) 0.97
Activity level and balance in subjects with mild Alzheimer's disease. Dement Geriatr Cogn Disord (2002) 0.96
Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study. Cerebrovasc Dis (2013) 0.96
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord (2009) 0.96
The dimensionality of between-person differences in white matter microstructure in old age. Hum Brain Mapp (2012) 0.96
Structural brain changes and cognition in relation to markers of vascular dysfunction. Neurobiol Aging (2011) 0.95
Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Curr Alzheimer Res (2012) 0.95
Regional vulnerability of hippocampal subfields to aging measured by structural and diffusion MRI. Hippocampus (2013) 0.94
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study. J Neurol (2012) 0.94
Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing. Psychiatry Res (2007) 0.93
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PLoS One (2012) 0.93
Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology (2006) 0.92
Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease. Neurobiol Aging (2008) 0.91
Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J Alzheimers Dis (2010) 0.91
Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD. Sci Rep (2013) 0.90
Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging (2010) 0.89
White matter hyperintensities and depression--preliminary results from the LADIS study. Int J Geriatr Psychiatry (2005) 0.89
Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis (2012) 0.89
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia. PLoS One (2013) 0.88
Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? Neurosci Lett (2006) 0.88
The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques. Acta Radiol (2011) 0.88
The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study. Am J Alzheimers Dis Other Demen (2006) 0.87
In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci (2009) 0.87
Shape analysis of the neostriatum in subtypes of frontotemporal lobar degeneration: neuroanatomically significant regional morphologic change. Psychiatry Res (2011) 0.87
Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging (2008) 0.87
Intramuscular and periosteal acupuncture for anxiety and sleep quality in patients with chronic musculoskeletal pain--an evaluator blind, controlled study. Acupunct Med (2007) 0.86
The predementia diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord (2004) 0.86
The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age. Front Hum Neurosci (2013) 0.86
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study. J Lipid Res (2009) 0.86
Long-term effects of new progressive group balance training for elderly people with increased risk of falling - a randomized controlled trial. Clin Rehabil (2012) 0.86
Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study. J Am Geriatr Soc (2008) 0.85
Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population. Acta Radiol (2012) 0.84
Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls. Neuroimage (2010) 0.84
Is the subcallosal medial prefrontal cortex a common site of atrophy in Alzheimer's disease and frontotemporal lobar degeneration? Front Aging Neurosci (2012) 0.84
Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines. J Neurol Sci (2012) 0.83
Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. Psychiatry Res (2013) 0.83
CSF/serum folate gradient: physiology and determinants with special reference to dementia. Dement Geriatr Cogn Disord (2008) 0.83
The relationship between head size and intracranial volume in elderly subjects. Brain Res (2003) 0.83